UBS Group AG Buys 236,152 Shares of Aveanna Healthcare Holdings Inc. $AVAH

UBS Group AG raised its stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 149.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 394,182 shares of the company’s stock after acquiring an additional 236,152 shares during the period. UBS Group AG’s holdings in Aveanna Healthcare were worth $3,220,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after acquiring an additional 1,535,351 shares in the last quarter. Teacher Retirement System of Texas lifted its stake in Aveanna Healthcare by 49.5% during the 4th quarter. Teacher Retirement System of Texas now owns 335,506 shares of the company’s stock valued at $2,741,000 after acquiring an additional 111,131 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Aveanna Healthcare during the 4th quarter valued at $830,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Aveanna Healthcare by 66.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,556 shares of the company’s stock valued at $307,000 after acquiring an additional 14,947 shares in the last quarter. Finally, Oak Thistle LLC bought a new position in Aveanna Healthcare during the 4th quarter valued at $101,000. 87.96% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Royal Bank Of Canada raised their price objective on Aveanna Healthcare from $9.00 to $10.00 and gave the company a “sector perform” rating in a research note on Friday, May 15th. Barclays dropped their price objective on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a research note on Monday, May 18th. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $10.00 to $11.00 in a research note on Friday, May 15th. Weiss Ratings cut Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, April 6th. Finally, BMO Capital Markets dropped their price objective on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, March 20th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Aveanna Healthcare has a consensus rating of “Moderate Buy” and an average target price of $10.50.

Insider Activity at Aveanna Healthcare

In other news, insider Patrick A. Cunningham sold 125,000 shares of Aveanna Healthcare stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the sale, the insider directly owned 212,755 shares in the company, valued at $1,614,810.45. The trade was a 37.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 5.30% of the stock is owned by insiders.

Aveanna Healthcare Stock Performance

NASDAQ AVAH opened at $7.33 on Monday. The stock has a market capitalization of $1.60 billion, a price-to-earnings ratio of 6.21, a PEG ratio of 0.87 and a beta of 1.93. Aveanna Healthcare Holdings Inc. has a one year low of $3.73 and a one year high of $10.32. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The business’s fifty day moving average is $6.75 and its 200-day moving average is $7.84.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The company had revenue of $647.92 million for the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The firm’s revenue was up 15.9% compared to the same quarter last year. Equities research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.56 EPS for the current year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.